Week of June 20, 2023 | Vol. 12, Issue 24

Linkedin  

In This Issue

Upcoming Events

Industry M&A Activity

Recent Transactions

Trading Comps

Market Reports

M&A Pipeline

Featured Headlines

Tanner Updates



Quick Links

Who We Are

M&A Discussion Group

Daybreak Consumer Care

Carlin Consumer Health


Contact Information

Xan Smith

Managing Director

Business Development

xsmith@bourne-partners.com


Jeremy C. Johnson

Managing Director

Head of M&A and Capital Advisory

jjohnson@bourne-partners.com

Industry Snapshot
Above is an overview of recent industry M&A activity. Click on the chart to view complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.

UPCOMING EVENTS

Events Hosted or Attended by Bourne Partners

DIA Global 2023

June 25-29, 2023 - Boson, MA

Contract Pharma 2023

September 5-8, 2023 - New Brunswick, NJ

Bourne Partners Annual Summit 2023

Invitation Only

October 4, 2023 - Charlotte, NC

INDUSTRY M&A ACTIVITY

Recent Transactions, Trading Comps, Market Reports, M&A Pipeline

Recent Transactions

An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

M&A Transactions

Pharma & Biotech

10 transactions totaling $5.0 billion


Supplies, Equipment & Services

19 transactions totaling $138 million


Healthcare Facilities & Distributors

7 transactions totaling $41 million


Healthcare IT & Managed Care

11 transactions totaling $93 million

Private Placements

Pharma & Biotech

30 transactions totaling $522 million


Supplies, Equipment & Services

22 transactions totaling $391 million


Healthcare Facilities & Distributors

4 transactions totaling $10 million


Healthcare IT & Managed Care

7 transactions totaling $27 million

Public Offerings

Pharma & Biotech

25 transactions totaling $1.9 billion


Supplies, Equipment & Services

5 transactions totaling $486 million


Healthcare Facilities & Distributors

3 transactions


Healthcare IT & Managed Care

2 transactions totaling $50 million

Trading Comps

A Breakdown of Relevant Trading Multiples

This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

Market Reports

Insight Into Healthcare Related Industries

Pharma Services Sector Snapshot 1H 2022

August 2022

Market Insight Capital Markets Update

October 2022

M&A Pipeline

Representative Current Retained Sell-Side and Partnering Opportunities

Project Beach

Pharma Services | Sell-Side

Acquisition opportunity of Clinical Trial Services Provider


Project Elevate

Pharma Services | Capital Raise

Investment opportunity in Digital Health patient adherence platform


Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product

Project Harold

Pharma Services | Sell-Side

Acquisition opportunity of U.S. based Sterile CDMO


Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable Pharmaceutical Manufacturer 


Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

Featured Headlines

A Sampling of Industry Headlines

Novartis inks $3.2B Chinook buyout to lift kidney disease plans

Fierce Biotech - Jun 12, 2023

Quell Therapeutics and AstraZeneca partner on Treg cell therapies

Pharmaceutical Technology - Jun 12, 2023

Charles River and Curigin Collaborate to Produce Oncolytic RNAi Gene Therapy

Business Wire - Jun 12, 2023

Sanofi goes 'all in' on AI with new app to support company's manufacturing, R&D and more

Fierce Biotech - Jun 14, 2023

Senju Pharmaceutical and Novaliq close agreement for dry eye disease therapy

Pharmaceutical Technology - Jun 14, 2023

Pfizer says penicillin injection may soon be in short supply

Endpoints News - Jun 14, 2023

BC Platforms acquires Scandinavian CRO 4Pharma for undisclosed price

Fierce Biotech - Jun 14, 2023

Thaerapy BV and Resyca® BV Announce Exclusive License Agreement for Soft Mist Inhaler Technology

Resyca - Jun 15, 2023

Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders

PR Newswire - Jun 15, 2023

Lilly adds to gene editing arsenal, paying Verve $60M for preclinical cardiovascular program

Fierce Biotech - Jun 15, 2023

TANNER NEWS

Linkedin  

Tanner Announces New US Operations Facility


Tanner Pharma is embarking on a new chapter of growth and expansion with the start of construction for a new operations facility in Charlotte, NC USA. Learn more.

Let's Connect!

The Tanner team will be attending several networking events in the coming weeks. Let’s connect to discuss how our organizations can improve patient lives, together.